Executive Reshuffles: LLY, S and RY Companies in Focus
Vir Biotechnology Enhances Portfolio With Sanofi Deal and Executive Appointments
Vir Biotechnology Appoints Jason O'Byrne as Chief Financial Officer
Express News | Vir Biotechnology Appoints Jason O’byrne as Chief Financial Officer
Sanofi Shares Are Trading Lower After Vir Biotechnology Announced the Closing of an Exclusive License Agreement With the Company.
Vir Biotechnology Announces Closing Of Exclusive Worldwide License Agreement With Sanofi For Multiple Potential Best-In-Class Clinical-Stage T-Cell Engagers; Strategic Agreement Expands Vir Portfolio With Three Clinical Stage Assets In Areas Of High...